IndiaTickerReply to Clarification- Financial results - Bal Pharma LimitedNSE · financial results · pdf
Source filing Company dossier
Bal Pharma
NSE:BALPHARMA · ISIN INE083D01012
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bal Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Bal Pharma Ltd - 524824 - Intimation Regarding Corrigendum To The Postal Ballot NoticeBSE · exchange filing · pdf
Source filing Corrigendum - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Shareholders meeting - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing Updates - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Trading Window - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Appointment of Company Secretary and Compliance OfficerBSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Bal Pharma Ltd - 524824 - Non Applicability Of Statement Of Deviation & VariationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Bal Pharma LimitedNSE · financial results · pdf
Source filing Statement of deviation(s) or variation(s) under Reg. 32 - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Audited Financial Results-Standalone & ConsolidatedBSE · financial results · pdf
Source filing Bal Pharma Ltd - 524824 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · financial results · pdf
Source filing Outcome of Board Meeting - Bal Pharma LimitedNSE · financial results · pdf
Source filing Outcome of Board Meeting - Bal Pharma LimitedNSE · financial results · pdf
Source filing Dividend - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Announcement under Regulation 30 (LODR)-Meeting UpdatesBSE · exchange filing · pdf
Source filing Corrigendum - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Board Meeting Intimation for Intimation Of The Board MeetingBSE · financial results · pdf
Source filing Bal Pharma Ltd - 524824 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerBSE · exchange filing · pdf
Source filing Resignation of Director/KMP/SMP - Bal Pharma LimitedNSE · exchange filing · zip
Source filing Disclosure under SEBI Takeover Regulations - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Structural Digital Database - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Trading Window - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Bal Pharma LimitedNSE · financial results · pdf
Source filing Bal Pharma Ltd - 524824 - Financial Results_31.12.2025BSE · financial results · pdf
Source filing Bal Pharma Ltd - 524824 - Board Meeting Outcome for Outcome Of The Board Meeting_ Standalone And Consolidated Financial Results For The Quarter Ended 31.12.2025.BSE · financial results · pdf
Source filing Outcome of Board Meeting - Bal Pharma LimitedNSE · financial results · pdf
Source filing Bal Pharma Ltd - 524824 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Shareholders meeting - Bal Pharma LimitedNSE · exchange filing · pdf
Source filing Bal Pharma Ltd - 524824 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31.12.2025.BSE · financial results · pdf
Source filing